GeneDx Holdings (WGS) Capital Leases (2020 - 2021)

GeneDx Holdings (WGS) reported Capital Leases of $18.4 million for Q4 2021, down 11.31% year-over-year from $20.8 million in Q4 2020, and down 11.31% quarter-over-quarter from $20.8 million in Q4 2020.

GeneDx Holdings (WGS) Capital Leases (2020 - 2021) Analysis & Trends

GeneDx Holdings (WGS) has 2 years of Capital Leases data on file, last reported at $18.4 million in Q4 2021.

  • Capital Leases for Q4 2021 came in at $18.4 million, down 11.31% year-over-year; the trailing twelve-month figure through Dec 2021 was $18.4 million (down 11.31% YoY), and the FY2021 annual result was $18.4 million, down 11.31% from the prior year.
  • Capital Leases fell to $18.4 million in Q4 2021 per WGS's latest filing, from $20.8 million in the prior quarter.
  • Over five years, Capital Leases peaked at $20.8 million in Q4 2020 and troughed at $18.4 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn
10 GeneDx Holdings 1.65 Bn 1.48 Bn 68.21 Mn

Historic Data

Download Data
DateValue
Dec 31, 2021 18.43 Mn
Dec 31, 2020 20.78 Mn